RFXAP and pancreatic neoplasm: MiR-212-3p is also overexpressed in pancreatic cancer-derived exosomes, which make DCs unable to activate CD4+ T cells by inhibiting the expression of the regulatory factor X-associated protein (RFXAP) and consequently decreasing MHC II expression [98, 99].